BBT
Beacon Financial Corp.
BBT's fundamentals are strong: revenue grew 84% and its operating margin rose 29 points to 35%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
BBT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BBT's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BBT.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
BBT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.4x | $30.68 | — |
| Cheap | 9.8x | $26.30 | -14% |
| Current | 11x | $30.68 | — |
| Fair | 14x | $37.89 | +24% |
| Expensive | 24x | $65.84 | +115% |
Historical ranges are pointers, not guarantees.
BBT's PE is 11x, but its earnings don't support one, so it isn't a reliable read right now.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
BBT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect BBT's profitability to improve, with its earnings and revenue holding steady.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
BBT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.26 | +21% |
| Q3 2026 | $2.69 | +142% |
| Q2 2026 | $1.39 | -46% |
| Q1 2026 | $1.28 | -48% |
| Q4 2025 | $1.29 | -10% |
| Q3 2025 | $1.11 | +17% |
| Q2 2025 | $2.56 | +392% |
| Q1 2025 | $2.47 | +394% |
| Q4 2024 | $1.44 | -10% |
BBT has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
BBT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $223.2M | +54% |
| Q2 2026 | $219.2M | +93% |
| Q1 2026 | $214.7M | +94% |
| Q4 2025 | $225.7M | +105% |
| Q3 2025 | $145M | +15% |
| Q2 2025 | $113.7M | +4.6% |
| Q1 2025 | $110.4M | +99% |
| Q4 2024 | $110.2M | +38% |
BBT's revenue has grown year over year for nine quarters in a row: $223M last quarter, up 54% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 37% | +86 points |
| Q2 2026 | 40% | +3.2 points |
| Q1 2026 | 31% | -0.6 points |
| Q4 2025 | 33% | +9.2 points |
| Q3 2025 | -50% | -88 points |
| Q2 2025 | 37% | +7.8 points |
| Q1 2025 | 31% | +79 points |
| Q4 2024 | 24% | +32 points |
BBT has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
BBT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $95.5M | +$99.1M |
| Q2 2026 | $64.1M | +77% |
| Q1 2026 | -$13.8M | -170% |
| Q4 2025 | $159.6M | +381% |
| Q3 2025 | -$3.6M | -108% |
| Q2 2025 | $36.3M | +5.5% |
| Q1 2025 | $19.9M | +200% |
| Q4 2024 | $33.2M | -35% |
BBT has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
BBT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +58.1K shares |
| 1 year | -4% | -3.5M shares |
| 3 years | +94% | +40.7M shares |
| 5 years | +72% | +35.3M shares |
| Available history | +66% | +33.3M shares |
BBT has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $2,000 |
| Q3 2024 | $1,000 |
| Q2 2024 | $13.5M |
| Q1 2024 | $4M |
| Q4 2023 | $6.7M |
| Q3 2023 | $3.6M |
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
BBT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2019 | 1.8x | Healthy |
BBT's net debt is about 1.8 years of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like BBT.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
BBT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.9 | Neutral |
| Stochastic | 65.5 | Neutral |
BBT's weekly RSI is 54 (neutral) and its Stochastic is 66 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
BBT PE vs Financial Services Sector
| Metric | BBT | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 12% below |
| PE % | 36 | 63 | 27 pts below |
BBT is trading at 11x earnings, a 12% discount to the Financial Services sector's median of 13x, though its earnings don't support one.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
BBT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.2 | 5.2% above |
| 20 week MA | $30.3 | 1.2% above |
| 50 week MA | $29.6 | 3.7% above |
| 100 week MA | $27.8 | 11% above |
| 200 week MA | $25.9 | 19% above |
BBT has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
BBT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.8 | $17.6 | -46% |
| 2021 | $17.6 | $28.4 | +61% |
| 2022 | $28.4 | $29.6 | +4.3% |
| 2023 | $29.6 | $24.8 | -16% |
| 2024 | $24.8 | $28.3 | +14% |
| 2025 | $28.3 | $26.9 | -4.9% |
| 2026 YTD | $26.9 | $30.7 | +14% |
BBT has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.